What is Erlocip 150 mg Tablet ?
Erlocip 150 mg, manufactured by Cipla, contains “Erlotinib” as an active ingredient. It belongs to a class of medicines called tyrosine kinase inhibitor. It is a prescription cancer drug and should not be taken without a doctor’s consent. Do not share this medicine with others because it can cause serious side effects to people until the condition is not monitored by health care professionals.
Erlocip 150 mg Tablets Uses :
Erlocip (Erlotinib hydrochloride) is a drug used to treat advanced-stage Non-small cell lung cancer (NSCLC), Pancreatic cancer and several other types of cancer.
Erlocip Erlotinib 150 mg Tablets Work :
In cancer, certain cells in the body grow and multiply in a way that is ‘out of control’. Erlotinib inhibits the way the cells grow and increase in number. It works by interfering with certain enzymes called tyrosine kinases that are important in transmitting the chemical signals needed for essential processes like cell division and replication in cancer cells. This in turn stops the cancer cells from growing and increasing in number.
How should Erlocip be taken?
You should take your Thuốc erlocip 150 mg swallowed whole with a glass of water at least one hour before or two hours after the ingestion of food. The dose you take and for how long depends on what you are being treated for and your doctor’s recommendation. For pancreatic cancer you should take your Erlocip tablets 150mg in combination with gemcitabine. You should continue to take your Erlocip tablets 150mg until your disease becomes worse or you show signs of toxicity from the medication, dependent on your doctor’s recommendation.
• Most Common : Rash and diarrhea.
• General : Fatigue, loss of appetite, itching, pimples, skin inflammation, dry skin, fever, fluid retention and decreased weight.
• Gastrointestinal : Nausea, abdominal pain, vomiting, constipation, indigestion and flatulence.
• Musculoskeletal : Bone pain and muscle pain.
• Respiratory : Difficulty in breathing and cough.
• Central Nervous System : Depression, dizziness, headache, sleeplessness, anxiety, nerve disease and rigors.
When should Erlocip not be used?
You should not use Erlocip tablets 150mg if you:
- are allergic to erlotinib or any ingredients in Erlocip
- are pregnant or are breastfeeding
- have kidney or liver disease
- are having immunisation with live vaccine
- use contact lenses and/or have a history of eye problems
- have gastrointestinal problems particularly diarrhoea as this can worsen with Erlocip
- have prior history of peptic ulceration or diverticular disease as this can increase risk of gastrointestinal perforation
- are a smoker
Warnings and Precautions for Erlocip (150mg)
• Caution should be exercised in patients with history of stomach problem, liver, kidney, or heart disease, dehydration, had radiation therapy, any allergy, who are taking other medications, elderly, children, during pregnancy and breastfeeding.
• It may reduce platelet counts; avoid injury or bruising.
• Avoid exposure to sunlight; otherwise it may cause sunburn easily.
• Monitor liver, kidney or lung function, eye examinations, and blood electrolytes regularly while taking this medication.
• Avoid contact with people who have infections.
Erlocip 150 mg – Storage Details :
Patients must properly store the drug to retain its quality and efficacy. Following storage instructions will be helpful in storing the drug in the best of manner.
- Store Erlotinib at 25°C (77°F); excursions are permitted between 15°C to 30°C (59°F to 86°F).
• Don’t leave this oncology medicine in places that are easily accessible to children or pets.
• Keep your medicine in the original container until it is time to take them.
• Store your medicine in an area that is convenient, but is also cool and dry – since heat and humidity can damage medicines.
• Keep your medicines separate from those of your spouse or other family members. This will make it less likely that you take the wrong ones by mistake.